Molecular Medicine Reports

OCT 22, 2026 · JOURNAL ARTICLE

Research progress in neural regulatory mechanisms and targeted therapy of obesity (Review)

Molecular Medicine Reports

obesity is a multifactorial chronic metabolic disease driven by disrupted energy homeostasis and excessive adipose tissue (aT) deposition under genetic, environmental and central n

SEP 17, 2026 · JOURNAL ARTICLE

Artemisinin and its derivatives for metabolic syndrome: From multi‑target mechanisms to translational opportunities (Review)

Molecular Medicine Reports

Metabolic syndrome (MetS) is a complex of disorders, characterized by insulin resistance accompanied by abdominal obesity, dyslipidemia, hypertension and impaired glucose metabolis

SEP 15, 2026 · JOURNAL ARTICLE

High‑fat diet exacerbates hepatic and adipose insulin signaling impairment and ovarian lesions in a rat model of letrozole‑induced polycystic ovary syndrome

Molecular Medicine Reports

Polycystic ovary syndrome (PcoS) is a multifactorial endocrine disorder characterized by ovarian dysfunction and metabolic abnormalities, including insulin resistance.letrozole (le

SEP 8, 2026 · JOURNAL ARTICLE

Research progress of aptamers in the diagnosis and treatment of colorectal cancer (Review)

Molecular Medicine Reports

This is a narrative review synthesizing preclinical and early-stage research on aptamers for colorectal cancer, raising opportunities rather than reporting primary trial evidence or definitive clinical results.

SEP 8, 2026 · JOURNAL ARTICLE

Role of the circadian rhythm in squamous cell carcinoma: From molecular mechanism to therapy (Review)

Molecular Medicine Reports

A review article summarizing mechanistic and preclinical evidence on circadian regulation in squamous cell carcinoma, explicitly acknowledging predominance of preclinical studies and limited clinical evidence, raising questions for future research rather than establishing clinical practice.

SEP 3, 2026 · JOURNAL ARTICLE

Licoisoflavone A ameliorates adipose tissue dysfunction in diet‑induced obesity by promoting METTL3 expression

Molecular Medicine Reports

First-in-vivo mechanistic study of a natural compound in diet-induced obesity using surrogate endpoints (body weight, lipid metabolism, insulin resistance) without clinical outcomes or human data.